Hypersensitivity to ceftriaxone or other cephalosporins. Neonates 41 wk corrected gestational age w/ jaundice, hypoalbuminaemia, or acidosis; hyperbilirubinaemic neonates esp prematures. Concomitant treatment w/ IV Ca (including TPN containing Ca) in neonates >41 wk corrected gestational age.